NCT05334316View on ClinicalTrials.gov

Individualizing Corticosteroid Use in Pneumonia

PHASE2RecruitingINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions

Pneumonia

Interventions

DRUG

Dexamethasone

Administered intravenously or orally based on daily CRP values and CRP corticosteroid dosing algorithm

Trial Locations (1)

55905

RECRUITING

Mayo Clinic Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER

NCT05334316 - Individualizing Corticosteroid Use in Pneumonia | Biotech Hunter | Biotech Hunter